Mavacamten improves energy balance in a pre-clinical model of RASopathy-associated hypertrophic cardiomyopathy
Andrea Ruiz‐Velasco, Charlène Jouve, Lucille Deshayes…·Jean‐Sébastien Hulot
This study evaluates mavacamten's effects on energy balance in RASopathy-associated HCM using hiPSC-CMs with a BRAF mutation.